Multimodal Chromatography for Specialized Environments

An innovative multimodal chromatography method for purifying HIV-1 envelope glycoprotein tailored for high-security biodefense, disaster relief, extreme weather conditions, and other niche applications.

The original patent disclosed a multimodal chromatography method for purifying HIV-1 envelope glycoprotein. However, this method had limitations in its adaptability to specific, narrow market or unique operational environments. The present inventive concept addresses these limitations by providing specialized variations and niche solutions for high-security biodefense, disaster relief, extreme weather conditions, and other applications.

The inventive concept comprises a family of multimodal chromatography methods and systems tailored for specific environments and applications. For high-security biodefense, the method involves capturing the HIV-1 envelope glycoprotein on a multimodal resin under controlled atmospheric conditions and eluting the captured glycoprotein with a sterile, decontaminated elution buffer. For disaster relief, a portable, self-contained multimodal chromatography unit is used, powered by a source adapted for extreme weather conditions. In extreme cold-weather environments, the method involves capturing the HIV-1 envelope glycoprotein on a multimodal resin at a temperature below -20°C and eluting the captured glycoprotein with a cryoprotectant-containing elution buffer. In high-altitude, low-oxygen environments, the method involves capturing the HIV-1 envelope glycoprotein on a multimodal resin in a pressurized, oxygen-enriched chamber and eluting the captured glycoprotein with an oxygen-rich elution buffer. Finally, in high-containment, biosafety level 4 laboratories, the system comprises a multimodal chromatography unit enclosed in a hermetically sealed, negatively pressurized chamber, and a robotic arm for automated, contact-free sample handling.

The inventive concept's novelty lies in its adaptation of the original multimodal chromatography method to specific, narrow market or unique operational environments. The inventive step resides in the identification of the need for specialized variations and niche solutions and the provision of tailored methods and systems to address these needs.

Alternative embodiments of the inventive concept could include the use of different multimodal resins, elution buffers, or operating conditions tailored to specific environments or applications. Additionally, the inventive concept could be implemented using different types of chromatography, such as affinity or ion-exchange chromatography.

The inventive concept has significant commercial potential in the biotechnology and pharmaceutical industries, particularly in the development of vaccines and therapeutics for infectious diseases. The target markets include high-security biodefense, disaster relief, and extreme weather conditions, as well as high-containment, biosafety level 4 laboratories.